Inhibitory Effects of Modified Wuzi Yanzong Prescription on LPS-induced Inflammatory Response on BV-2 Microglial Cells

SONG Fang-jiao,SONG Yi-xiang,ZENG Ke-wu,TU Peng-fei,WANG Xue-mei
DOI: https://doi.org/10.11653/syfj2013240177
2013-01-01
Abstract:Objective: To study the inhibitory effects of modified Wuzi Yanzong prescription(MWP) on BV-2 microglial cells induced by lipopolysaccharides(LPS) and the potential mechanism. Method: BV-2 microglial cells were cultured in vitro and stimulated by LPS(1 mg·L- 1). The cells were divided into three groups: blank control group,model group and MWP treatment group. The gradient 50,100,200 mg·L- 1three concentrations were used in the treatment group. The expression of inflammatory factor nitric oxide(NO),protein inducible nitric oxide synthese(iNOS) and cyclooxygenase(COX-2),the translocation of nuclear factor-κB(NF-κB),nicotinamide adenosine denucleotide hydrophosphori(NADPH) oxidase activity and reactive oxygen species were tested after treating the cells by LPS and MWP. Result: MWP could decrease the release of NO and expression of iNOS,COX-2 protein with a dose-dependent manner,the nuclear translocation of NF-κB was inhibited by MWP too. In addition,MWP could decrease the NADPH oxidase activity with a dose-dependent manner and significantly reduced the generation of ROS. Conclusion: MWP can significantly inhibit the inflammatory response of BV-2 microglial cells induced by LPS via suppression of NF-κB signaling pathway and NADPH oxidase-mediated oxidative stress.
What problem does this paper attempt to address?